Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
51.46B | 41.92B | 54.15B | 39.57B | 29.56B | 12.00B | Gross Profit |
9.78B | 10.40B | 8.31B | 7.17B | 5.54B | 3.35B | EBIT |
6.22B | 6.73B | 5.31B | 4.03B | 3.28B | 396.00M | EBITDA |
6.71B | 7.70B | 6.12B | 4.54B | 11.47B | -4.64B | Net Income Common Stockholders |
3.95B | 4.39B | 3.45B | 2.44B | 10.36B | -7.65B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.82B | 60.71B | 63.64B | 35.58B | 20.30B | 9.25B | Total Assets |
104.80B | 105.78B | 75.70B | 48.35B | 29.80B | 40.85B | Total Debt |
73.83B | 72.40B | 48.90B | 23.21B | 15.12B | 37.33B | Net Debt |
62.01B | 63.47B | 36.25B | 9.39B | 6.50B | 31.95B | Total Liabilities |
82.34B | 80.60B | 54.59B | 30.58B | 16.64B | 38.47B | Stockholders Equity |
22.47B | 25.17B | 21.11B | 17.78B | 13.16B | 2.38B |
Cash Flow | Free Cash Flow | ||||
0.00 | -26.51B | -26.69B | -4.54B | -814.00M | 2.74B | Operating Cash Flow |
0.00 | -26.51B | -26.65B | 3.71B | -772.00M | 2.75B | Investing Cash Flow |
0.00 | -123.00M | -189.00M | -8.43B | 26.08B | 7.79B | Financing Cash Flow |
0.00 | 22.93B | 25.62B | 9.94B | -22.20B | -11.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥27.27B | 7.39 | 5.67% | 17.40% | 17.97% | ||
76 Outperform | ¥777.95B | 9.07 | 4.17% | 1.67% | 18.48% | ||
76 Outperform | ¥10.28B | 7.97 | 4.21% | 6.95% | 4.92% | ||
70 Outperform | ¥30.81B | 6.77 | 2.56% | -22.59% | 26.95% | ||
69 Neutral | ¥109.07B | 8.73 | 2.88% | 8.56% | 16.30% | ||
67 Neutral | ¥355.07B | 7.81 | 3.91% | -4.25% | -4.22% | ||
66 Neutral | $4.51B | 12.22 | 5.40% | 3.63% | 4.14% | -12.01% |